Sema4 advances precision oncology by
combining best-in-class molecular profiling
with rich longitudinal data to deliver comprehensive, actionable real-world evidence
Are you looking to collaborate?
Sema4’s advanced predictive modeling and data science expertise uniquely position us to deliver value to and accelerate discovery for collaborators in biopharma, healthcare, and research.
Download our Research Highlight to learn how Sema4 is helping to identify new cancer therapies through integrative network analysis.
View additional Sema4 studies and research:
- REPRESENT Study, enables access to comprehensive genetic and genomic testing for advanced cancer patients in underserved communities. Read more >>
- Research Highlight: Value-Added Clinical Tumor/Normal Whole Exome and Whole Transcriptome Sequencing vs a DNA and RNA Tumor Only Gene Panel for Managing Breast Cancer. Download research >>
Poster Session: Monday June 6th, 1:15-4:15 p.m. CDT
Learn more about Sema4’s latest research by scheduling time to meet with our team via Calendly.